Covered recipient · General Payments record
SAFRIN ALI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,774.80
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $382.76 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $106.19 | 3 |
| Novo Nordisk AS | $71.85 | 4 |
| Corcept Therapeutics | $42.75 | 2 |
| Lilly USA, LLC | $38.75 | 2 |
| Antares Pharma, Inc. | $25.03 | 1 |
| BETA BIONICS, INC. | $22.50 | 1 |
| Tandem Diabetes Care, Inc. | $21.08 | 1 |
| Abbott Laboratories | $20.47 | 1 |
| Amphastar Pharmaceuticals, Inc. | $18.67 | 1 |
| DEXCOM, INC. | $15.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.47 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124829841 | CMS |
| Amphastar Pharmaceuticals, Inc. | $18.67 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149953650 | CMS |
| Antares Pharma, Inc. | $25.03 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146494476 | CMS |
| BETA BIONICS, INC. | $22.50 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087890761 | CMS |
| Corcept Therapeutics | $24.86 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117766173 | CMS |
| Corcept Therapeutics | $17.89 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117766187 | CMS |
| Dexcom, Inc. | $15.47 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153384544 | CMS |
| Lilly USA, LLC | $19.38 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135883921 | CMS |
| Lilly USA, LLC | $19.37 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902026 | CMS |
| Medtronic, Inc. | $57.06 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116902358 | CMS |
| Medtronic, Inc. | $23.86 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116902360 | CMS |
| Medtronic, Inc. | $25.27 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116902362 | CMS |
| Novo Nordisk Inc | $24.86 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100512309 | CMS |
| Novo Nordisk Inc | $13.68 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100228656 | CMS |
| Novo Nordisk Inc | $17.22 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100343306 | CMS |
| Novo Nordisk Inc | $16.09 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100511009 | CMS |
| Tandem Diabetes Care, Inc. | $21.08 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138748399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.